ICSL Pharma

Innovative Clinical Solutions, Ltd. (ICSL) was a prominent clinical research organization (CRO) and site network provider that supported the pharmaceutical and biotechnology industries. Headquartered in Providence, Rhode Island, the company specialized in clinical and economic research, disease management, and managed care functions for specialty provider networks. ICSL operated an extensive oncology clinical studies (OCS) network with over 20 sites across the United States, offering Phase I-IV clinical trial support services including protocol design, patient recruitment, and data analysis. The company was publicly traded on the OTC Bulletin Board under the symbol ICSN before its assets were divested to various entities in the early 2000s.